Add BrightSurf on Google Email

Science News for January 3, 2000


Study shows one anti-rejection drug works better to prevent harmful blood clots in heart transplant patients

A University of Maryland Medical Center study found that FK506 significantly lowers the risk of forming clots compared to cyclosporine. The research has important implications for understanding coronary disease after a transplant and improving outlook for heart transplant patients.

SourceUniversity of Maryland Medical Center·JournalThe Journal of Heart and Lung Transplantation·DateJan 3, 2000

Diet rich in beans may have positive impact on women's heart health, according to results of major study presented by Cedars-Sinai cardiologist

A nationwide study of 1,000 women found increased phytoestrogen levels associated with beneficial cholesterol levels and improved arterial function. The study suggests that consuming beans in plant form may be more effective than taking supplements, potentially reducing risk factors for heart disease in women.

Study reveals family secret of how viruses enter cells

A research group from Purdue University analyzed the interaction between poliovirus and its receptor, finding that it uses a similar site to bind as human rhinoviruses. The study provides new insights into how viruses selectively attach to receptors and may suggest ways for developing drugs to prevent illnesses caused by viral pathogens.

SourcePurdue University·JournalProceedings of the National Academy of Sciences·DateJan 3, 2000

University of Pittsburgh-led team finds biological reason for women's increased risk of smoking-related lung cancer

A University of Pittsburgh-led research team discovered that the gene for gastrin-releasing peptide receptor is more active in women than men, leading to increased cell proliferation and lung cancer growth. Nicotine from cigarettes also stimulates this gene expression, explaining why women are at a higher risk of developing lung cancer...

SourceUniversity of Pittsburgh Medical Center·JournalJNCI Journal of the National Cancer Institute·DateJan 3, 2000